PainReform Ltd.
PRFX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | -100% | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | -$0 | -$0 | $0 | -$0 |
| % Margin | – | – | 82.6% | – |
| R&D Expenses | $12 | $6 | $4 | $3 |
| G&A Expenses | $3 | $3 | $4 | $4 |
| SG&A Expenses | $3 | $4 | $4 | $4 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $15 | $10 | $9 | $7 |
| Operating Income | -$15 | -$10 | -$9 | -$7 |
| % Margin | – | – | -10,312.8% | – |
| Other Income/Exp. Net | $0 | $0 | $0 | -$0 |
| Pre-Tax Income | -$15 | -$9 | -$9 | -$7 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$15 | -$9 | -$9 | -$7 |
| % Margin | – | – | -10,223.3% | – |
| EPS | -32.16 | -171.329 | -197.921 | -177.233 |
| % Growth | 81.2% | 13.4% | -11.7% | – |
| EPS Diluted | -32.16 | -171.329 | -197.921 | -177.233 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$15 | -$10 | -$9 | -$7 |
| % Margin | – | – | -10,180.2% | – |